Advertisement

Header Utility Menu

  • Subscribe
  • Advertise
  • Contact Us
  • Events

LinkedIn Facebook Twitter Instagram Get Our App

  • Login

Virginia Business

Mobile Menu

  • Issues
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • Women in Leadership
    • Legal Elite
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • Call for Nominations: 2024 Virginia Black Business Leaders Awards
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
    • Order Women In Leadership Plaques
  • Virginia 500
    • Read The Issue
    • Buy an award plaque
    • Suggest execs for 2024

Advertisement

Header Primary Menu

  • Issues
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • Issues Archive
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • Women in Leadership
    • Legal Elite
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • Call for Nominations: 2024 Virginia Black Business Leaders Awards
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
    • Order Women In Leadership Plaques
  • Virginia 500
    • Read The Issue
    • Buy an award plaque
    • Suggest execs for 2024

Home News Regions Civica to produce lower-cost insulin

Civica to produce lower-cost insulin

Published April 28, 2022 by Kate Andrews

L to R: Petersburg Mayor Samuel Parham, U.S. Sen. Tim Kaine and Stan Benson, site head of Civica Petersburg, tour the nonprofit drugmaker’s new facility. Photo by Kate Andrews
L to R: Petersburg Mayor Samuel Parham, U.S. Sen. Tim Kaine and Stan Benson, site head of Civica Petersburg, tour the nonprofit drugmaker’s new facility. Photo by Kate Andrews

Civica Rx, a nonprofit generic drug-maker with a pharmaceutical manufacturing plant under construction in Petersburg, plans to produce three forms of insulin priced at $30 per vial beginning in early 2024, a project that dovetails with a bill in Congress that would cap consumers’ out-of-pocket insulin costs.

Civica’s 140,000-square-foot, $124.5 million Petersburg production facility will become the Utah-based manufacturer’s North American headquarters when it opens in early 2024. Built to produce medicines for the treatment of COVID-19, the plant also will include space for insulin manufacturing, company representatives said during an April tour. Civica plans to hire up to 250 people for the factory, up from its original plan to hire 186 workers.

“We’ve had a bunch of large donors who are very concerned about diabetes and the cost of insulin come to us and ask us to [manufacture] insulin,” says Civica President and CEO Martin VanTrieste. The $30 insulin vials will cost “about 90% [less] than today’s list price,” he says. “And,” he adds, “as you know, the list price is a price no one pays unless you have no insurance.”

In April, the U.S. House of Representatives passed a bill to cap insulin prices at $35 a month or 25% of an insurance plan’s negotiated price, whichever is lower. According to the Health Care Cost Institute, insulin prices doubled between 2012 and 2016.

In Petersburg, Civica is partnering with Richmond-based Phlow Corp. and Rancho Cordova, California-based AMPAC Fine Chemicals to produce COVID drugs as part of a federal initiative to create a domestic supply chain for critical pharmaceuticals and ingredients. U.S. Sen. Tim Kaine visited the Civica plant, which is halfway completed, in April, participating in a roundtable discussion about drug costs and workforce training initiatives at the region’s universities and colleges.

Kaine supports the $35 out-of-pocket cap on insulin costs and hopes to revive a previous bill he introduced to allow students to use Pell Grant funds to pay for short-term certificate programs in pharmaceutical manufacturing and other vocational studies.

Aside from lowering consumer costs, Kaine says, producing medications domestically will help lighten the nation’s dependence on Chinese drug manufacturers.

“I think most of us feel better about the quality when it’s made here at home,” he says. “You don’t have to assume that China’s a bad actor, [but] in the next pandemic, they are naturally going to prioritize producing pharmaceuticals for their own population.” 

  Subscribe to Virginia Business. Get our daily e-newsletter.

Related Stories

Virginia Business logo

AMPAC expanding Petersburg operation, adding 156 jobs

Pharmaceutical manufacturer plans to invest $25 million

America is “dangerously dependent on foreign sources for some of our most critical essential medicines,” says Phlow CEO Dr. Eric Edwards (L), who co-founded the Richmond-based pharmaceutical startup with Frank Gupton (R).

Economic healing

Petersburg aims to become pharma hub

Dr. Eric Edwards

Trump administration chooses RVA pharma startup for $354M COVID-19 contract

Phlow Corp. will create domestic supply chain for coronavirus drugs

Trending

Youngkin signs executive directive on AI

Buc-ee’s buys land for second Va. location

Richmond lodge appeals court’s casino ruling

Amazon to open fulfillment, delivery facilities in Va. Beach

Kaine, Warner announce $100M for rail bridge in NoVa

Sponsored Stories

Part 2: 2024; logistics nightmare or a re-awakening?

Part 1: 2024 a year of Logistics nightmares or a re-awakening?

Are you the biggest target for cyber security bad actors?

Advertisement

Advertisement

Trending

Youngkin signs executive directive on AI

Buc-ee’s buys land for second Va. location

Richmond lodge appeals court’s casino ruling

Amazon to open fulfillment, delivery facilities in Va. Beach

Kaine, Warner announce $100M for rail bridge in NoVa

Sponsored Stories

Part 2: 2024; logistics nightmare or a re-awakening?

Part 1: 2024 a year of Logistics nightmares or a re-awakening?

Are you the biggest target for cyber security bad actors?

Get Virginia Business directly on your tablet or in your mailbox!

Subscribe to Virginia Business

Advertisement

Advertisement

Footer Primary Menu

  • virginiabusiness.com
  • Subscribe
  • Advertise
  • About Us
  • Contact Us

Footer Secondary Menu

  • Industries
  • Regions
  • Reports
  • Company News
  • Events

Sign Up For Our Newsletter

Sign Up

LinkedIn Facebook Twitter Instagram Get Our App

Privacy Policy Cookie Policy

Footer Utility Menu

Copyright © 2023 Virginia Business. All rights reserved.

Site Maintained by TechArk

wpDiscuz